AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7930256 — intervention group
Group type: COMPARATOR
Intervention: NG‐monomethyl‐L‐arginine (n = 10)
Number of subjects: 30
Study 3086359 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone infusion (8 mg in 1 min followed by 12 mg in 3 h)
Number of subjects: 0
Study 3086359 — intervention group
Group type: COMPARATOR
Intervention: Testosterone undecanoate, 40 mg three times a day by mouth
Number of subjects: 0
Study 3086359 — intervention group
Group type: COMPARATOR
Intervention: Testosterone enanthate 200 mg im every 2 weeks
Number of subjects: 0
Study 3086359 — intervention group
Group type: COMPARATOR
Intervention: Testosterone enanthate 100 mg im once a week
Number of subjects: 0
Study 30390646 — intervention group
Group type: EXPERIMENTAL
Intervention: Response inhibition smoking training (INST)
Number of subjects: 150
Study 30390646 — intervention group
Group type: COMPARATOR
Intervention: Active control group (response inhibition towards household items)
Number of subjects: 150
Study 26917682 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel raise
Number of subjects: 124
Study 26917682 — intervention group
Group type: COMPARATOR
Intervention: Prefabricated orthoses
Number of subjects: 124
Study 26917682 — intervention group
Group type: EXPERIMENTAL
Intervention: Footwear replacement
Number of subjects: 124
Study 26917682 — intervention group
Group type: COMPARATOR
Intervention: No footwear replacement
Number of subjects: 124
Study 24096769 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecolic route of gastroenteric reconstruction
Number of subjects: 246
Study 24096769 — intervention group
Group type: COMPARATOR
Intervention: Retrocolic route of gastroenteric reconstruction
Number of subjects: 246
Study 22488002 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil-based parenteral nutrition (Intralipid)
Number of subjects: 100
Study 22488002 — intervention group
Group type: COMPARATOR
Intervention: Olive oil-based parenteral nutrition (ClinOleic)
Number of subjects: 100
Study 21040626 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 97 mg L-theanine and 40 mg caffeine
Number of subjects: 44
Study 21040626 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 44
Study 18349061 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) (100 mug)
Number of subjects: 50
Study 18349061 — intervention group
Group type: COMPARATOR
Intervention: Daily PTH
Number of subjects: 50
Study 17703634 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan/Hydrochlorothiazide combination
Number of subjects: 0
Study 14987497 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal instructions on hygienic standards for collecting the sample and explanatory leaflet
Number of subjects: 515
Study 14987497 — intervention group
Group type: COMPARATOR
Intervention: Control group (customary guidelines)
Number of subjects: 515
Study 10770818 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 400 microg/day (FP400)
Number of subjects: 69
Study 10770818 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 800 microg/day (BDP800)
Number of subjects: 69
Study 10770818 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 750 microg/day (FP750)
Number of subjects: 69
Study 10770818 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 1500 microg/day (BDP1500)
Number of subjects: 69
Study 9075139 — intervention group
Group type: EXPERIMENTAL
Intervention: Icodextrin 7.5%
Number of subjects: 23
Study 8473588 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy challenge
Number of subjects: 3
Study 8473588 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional information
Number of subjects: 3
Study 8473588 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 3
Study 3084167 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing IUDs (20 micrograms or 30 micrograms per day)
Number of subjects: 10600
Study 3084167 — intervention group
Group type: COMPARATOR
Intervention: Copper-releasing IUD (Nova T)
Number of subjects: 10600
Study 3084167 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing IUDs (LNG-IUDs)
Number of subjects: 10600
Study 31837497 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0
Study 31837497 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 31144402 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: previous scores were shown before completing the PVAS
Number of subjects: 192
Study 31144402 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: PVAS was completed then owners were shown previous scores and asked to repeat the PVAS
Number of subjects: 192
Study 31144402 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: PVAS was completed as reported previously
Number of subjects: 192
Study 31144402 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D: PVAS and a 0–10 verbal scale (VS) were completed
Number of subjects: 192
Study 31144402 — intervention group
Group type: COMPARATOR
Intervention: Retrospective study
Number of subjects: 192
Study 28251932 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactisole (500 ppm) added to the preload and OGTT solutions
Number of subjects: 10
Study 28251932 — intervention group
Group type: COMPARATOR
Intervention: Control OGTT (water preload without lactisole)
Number of subjects: 10
Study 28251932 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharin (300 ppm) preload before OGTT
Number of subjects: 10
Study 25651363 — intervention group
Group type: EXPERIMENTAL
Intervention: ZS-9 3 g three times daily for 2 days
Number of subjects: 90
Study 25651363 — intervention group
Group type: EXPERIMENTAL
Intervention: ZS-9 10 g three times daily for 2 days
Number of subjects: 90
Study 25651363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 25651363 — intervention group
Group type: EXPERIMENTAL
Intervention: ZS-9 10 g
Number of subjects: 90
Study 24049442 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention
Number of subjects: 0
Study 21315223 — intervention group
Group type: EXPERIMENTAL
Intervention: VerifyNow P2Y12 Assay (Accumetrics)
Number of subjects: 222
Study 21315223 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyporesponsiveness to clopidogrel based on the VerifyNow Assay
Number of subjects: 222
Study 21315223 — intervention group
Group type: COMPARATOR
Intervention: VerifyNow Aspirin Assay (Accumetrics), MEA ASPI test, MEA ADP test
Number of subjects: 222
Study 19442776 — intervention group
Group type: EXPERIMENTAL
Intervention: NGM/EE
Number of subjects: 2810
Study 19442776 — intervention group
Group type: EXPERIMENTAL
Intervention: NETA/EE
Number of subjects: 2810
Study 19442776 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 2810
Study 16830021 — intervention group
Group type: EXPERIMENTAL
Intervention: Castor oil
Number of subjects: 47
Study 16830021 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 15120542 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed head injury group
Number of subjects: 0
Study 15120542 — intervention group
Group type: COMPARATOR
Intervention: Neurologically intact controls
Number of subjects: 0
Study 11131448 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate 400 mg/day for 14 days every 3 months for at least 1 year with supplemental calcium
Number of subjects: 67
Study 11131448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 9052046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraviolet C light (UVC) system
Number of subjects: 0
Study 8886085 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyalectin 20 mg
Number of subjects: 110
Study 8886085 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (Control)
Number of subjects: 110
Study 3021443 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane-nitrous oxide anaesthesia
Number of subjects: 20
Study 3021443 — intervention group
Group type: COMPARATOR
Intervention: Normotensive epidural analgesia
Number of subjects: 20
Study 31860209 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% lotion
Number of subjects: 865
Study 31860209 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 865
Study 28776873 — intervention group
Group type: EXPERIMENTAL
Intervention: STRIP (Systematic Tool to Reduce Inappropriate Prescribing)
Number of subjects: 0
Study 28776873 — intervention group
Group type: EXPERIMENTAL
Intervention: STRIP
Number of subjects: 0
Study 27033260 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous biopsy
Number of subjects: 393
Study 27033260 — intervention group
Group type: COMPARATOR
Intervention: No biopsy
Number of subjects: 393
Study 24651386 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated reciprocal peer review visits followed by 12 months of supported quality improvement
Number of subjects: 78
Study 24651386 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 78
Study 22686948 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (five tailored one-to-one sessions)
Number of subjects: 159
Study 20927416 — intervention group
Group type: EXPERIMENTAL
Intervention: NobelGuide System (Nobel Biocare)
Number of subjects: 20
Study 19022835 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular pacing
Number of subjects: 39
Study 19022835 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular pacing
Number of subjects: 39
Study 16086949 — intervention group
Group type: EXPERIMENTAL
Intervention: 350‐mm² Baerveldt glaucoma implant
Number of subjects: 212
Study 16086949 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (0.4 mg/ml for 4 minutes)
Number of subjects: 212
Study 12183313 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11475717 — intervention group
Group type: EXPERIMENTAL
Intervention: Weishu capsule (WSC)
Number of subjects: 75
Study 11475717 — intervention group
Group type: COMPARATOR
Intervention: Weining granule (WNG)
Number of subjects: 75
Study 7624468 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment for 8 weeks
Number of subjects: 148
Study 2708190 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate infusion
Number of subjects: 6
Study 2708190 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 6
Study 24031 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3 (alkalosis)
Number of subjects: 5
Study 24031 — intervention group
Group type: EXPERIMENTAL
Intervention: NH4Cl (acidosis)
Number of subjects: 5
Study 24031 — intervention group
Group type: COMPARATOR
Intervention: CaCO3 (control)
Number of subjects: 5
Study 24031 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidosis
Number of subjects: 5
Study 24031 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalosis
Number of subjects: 5
Study 31767215 — intervention group
Group type: EXPERIMENTAL
Intervention: internet delivered cognitive behaviour therapy (iCBT) for eight weeks, five sessions (n=150)
Number of subjects: 302
Study 31767215 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual (n=152)
Number of subjects: 302
Study 31287011 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in child/youth mental health treatment
Number of subjects: 0
Study 31287011 — intervention group
Group type: COMPARATOR
Intervention: Booster training on recognition and referral
Number of subjects: 0
Study 28371882 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezotome-corticision assisted orthodontics
Number of subjects: 41
Study 28371882 — intervention group
Group type: COMPARATOR
Intervention: Conventional orthodontics (self-ligation fixed orthodontic appliance without corticision)
Number of subjects: 41
Study 25363062 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus reuteri DSM 17938 strain supplementation
Number of subjects: 0
Study 25363062 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 22878868 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine treatment plus conventional therapy
Number of subjects: 13
Study 22878868 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 13
Study 22878868 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic patients (n=6)
Number of subjects: 13
Study 22878868 — intervention group
Group type: COMPARATOR
Intervention: Disease-free subjects (n=6)
Number of subjects: 13
Study 21804499 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron plus dexamethasone (Group A)
Number of subjects: 100
Study 21804499 — intervention group
Group type: COMPARATOR
Intervention: Granisetron (Group B)
Number of subjects: 100
Study 19538741 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) group, 1 gram diluted in 100 ml normal saline
Number of subjects: 38
Study 19538741 — intervention group
Group type: COMPARATOR
Intervention: Placebo group, 100 ml of normal saline
Number of subjects: 38
Study 19538741 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) group
Number of subjects: 38
Study 19538741 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 38
Study 19538741 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 16442406 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous low-dose vitamin K
Number of subjects: 102
Study 16442406 — intervention group
Group type: COMPARATOR
Intervention: Fresh frozen plasma (FFP)
Number of subjects: 102
Study 16442406 — intervention group
Group type: COMPARATOR
Intervention: FFP
Number of subjects: 102
Study 16442406 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K
Number of subjects: 102
Study 14872180 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-adapted trivalent intranasal influenza virus vaccine (CAIV)
Number of subjects: 9689
Study 14872180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9689
Study 11770835 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen CR (1,000 mg once daily)
Number of subjects: 159
Study 11770835 — intervention group
Group type: COMPARATOR
Intervention: nabumetone (1,000 mg once daily)
Number of subjects: 159
Study 11770835 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen CR
Number of subjects: 159
Study 11770835 — intervention group
Group type: COMPARATOR
Intervention: nabumetone
Number of subjects: 159
Study 11770835 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen CR and nabumetone
Number of subjects: 159
Study 9579815 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 37
Study 9579815 — intervention group
Group type: COMPARATOR
Intervention: Propafenone
Number of subjects: 37
Study 9579815 — intervention group
Group type: COMPARATOR
Intervention: Procainamide
Number of subjects: 37
Study 7995183 — intervention group
Group type: EXPERIMENTAL
Intervention: Purepa capsules, coated, pH 5.5, 60 min time release (group C)
Number of subjects: 50
Study 7995183 — intervention group
Group type: COMPARATOR
Intervention: Purepa capsules (other preparations A, B, D)
Number of subjects: 50
Study 7995183 — intervention group
Group type: COMPARATOR
Intervention: Max-EPA (triglyceride preparation)
Number of subjects: 50
Study 2741263 — intervention group
Group type: COMPARATOR
Intervention: Laser treatment only
Number of subjects: 137
Study 2741263 — intervention group
Group type: COMPARATOR
Intervention: Laser treatment plus 5-fluorouracil 5% ointment
Number of subjects: 137
Study 2741263 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment and adjuvant 5-fluorouracil 2% painting
Number of subjects: 137
Study 31542756 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction
Number of subjects: 75
Study 31542756 — intervention group
Group type: EXPERIMENTAL
Intervention: Building better caregivers manualised group-based intervention
Number of subjects: 75
Study 31542756 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 75
Study 29923005 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Number of subjects: 0
Study 29923005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27342767 — intervention group
Group type: EXPERIMENTAL
Intervention: Child perceptions of health related quality of life (QOL) using the Oxford Ankle Foot Questionnaire for Children (OxAFQ‐C)
Number of subjects: 124
Study 27342767 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent perceptions of health related quality of life (QOL) using the Oxford Ankle Foot Questionnaire for Children (OxAFQ‐C)
Number of subjects: 124
Study 25132588 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual Axis Rotational Coronary Angiography (DARCA)
Number of subjects: 201
Study 25132588 — intervention group
Group type: COMPARATOR
Intervention: Conventional Coronary Angiography (CCA)
Number of subjects: 201
Study 22219315 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 μg reduced-dose seasonal trivalent influenza vaccine
Number of subjects: 234
Study 22219315 — intervention group
Group type: COMPARATOR
Intervention: 15 μg conventional seasonal trivalent influenza vaccine
Number of subjects: 234
Study 21147694 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel, trastuzumab, and pertuzumab
Number of subjects: 800
Study 21147694 — intervention group
Group type: COMPARATOR
Intervention: docetaxel, trastuzumab, and placebo
Number of subjects: 800
Study 17693890 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered, modified directly observed therapy (mDOT) for 6 weeks (30 daily visits)
Number of subjects: 350
Study 17693890 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 350
Study 15848478 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic donor nephrectomy (LapDN)
Number of subjects: 60
Study 15848478 — intervention group
Group type: COMPARATOR
Intervention: Open donor nephrectomy
Number of subjects: 60
Study 12208571 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine 5 mg three times daily
Number of subjects: 39
Study 12208571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 9972741 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) 50 ng x kg(‐1) x min(‐1)
Number of subjects: 20
Study 9972741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7570406 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma self-management programme (four 2.5 hour education sessions at weekly intervals)
Number of subjects: 116
Study 7570406 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma self-management programme
Number of subjects: 116
Study 7570406 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 116
Study 2405935 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanically stapled anastomoses
Number of subjects: 80
Study 2405935 — intervention group
Group type: COMPARATOR
Intervention: Hand-sewn anastomoses (single layer Maxon)
Number of subjects: 80
Study 2405935 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (mechanically stapled and hand-sewn)
Number of subjects: 80
Study 466952 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (2 mg intravenous)
Number of subjects: 72
Study 466952 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (2 mg intravenous) in Series A
Number of subjects: 72
Study 466952 — intervention group
Group type: COMPARATOR
Intervention: Control (no glucagon) in Series A
Number of subjects: 72
Study 466952 — intervention group
Group type: COMPARATOR
Intervention: Control (no glucagon) in Series B
Number of subjects: 72
Study 6638849 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprobe analgesia
Number of subjects: 0
Study 6638849 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine infusion
Number of subjects: 0
Study 6638849 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of cryoprobe and morphine infusion
Number of subjects: 0
Study 6638849 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine on demand
Number of subjects: 0
Study 31298923 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex meniscal tear
Number of subjects: 40
Study 31298923 — intervention group
Group type: EXPERIMENTAL
Intervention: Meniscal extrusion of at least 11%, 25%, and 20%
Number of subjects: 40
Study 31298923 — intervention group
Group type: EXPERIMENTAL
Intervention: Tear lengths of at least 7.0 mm, 6.7 mm, and 6.5 mm
Number of subjects: 40
Study 31298923 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartilage injury in the medial compartment
Number of subjects: 40
Study 31298923 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 20% meniscal tissue excised
Number of subjects: 40
Study 29261565 — intervention group
Group type: EXPERIMENTAL
Intervention: Above goal oxygen exposure (cumulative 5-day above goal oxygen exposure)
Number of subjects: 2994
Study 26789096 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid supplementation (250 mg)
Number of subjects: 46
Study 26789096 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid supplementation (500 mg)
Number of subjects: 46
Study 26789096 — intervention group
Group type: COMPARATOR
Intervention: Control group (exercise without AA supplementation)
Number of subjects: 46
Study 26789096 — intervention group
Group type: EXPERIMENTAL
Intervention: AA supplementation (both dosages)
Number of subjects: 46
Study 24161333 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 145 (PCSK9 monoclonal antibody)
Number of subjects: 282
Study 22515646 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. epoprostenol at 2 ng kg(‐1) min(‐1) for 2 hours
Number of subjects: 20
Study 22515646 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. epoprostenol at 4 ng kg(‐1) min(‐1) for 2 hours
Number of subjects: 20
Study 22515646 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. epoprostenol at 6 ng kg(‐1) min(‐1) for 2 hours
Number of subjects: 20
Study 22515646 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. epoprostenol at 8 ng kg(‐1) min(‐1) for 2 hours
Number of subjects: 20
Study 22515646 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. epoprostenol
Number of subjects: 20
Study 19996931 — intervention group
Group type: EXPERIMENTAL
Intervention: High-stringency CD8-depleted DLI (starting dose: 1 x 10(6) CD4 cells/kg for unrelated, 3 x 10(6) CD4 cells/kg for related)
Number of subjects: 28